Statistics

Total Visits

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib75

Select a period of time:

Number of views in the range

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib18

Views

Views
October 20255
November 20251
December 20252
January 20262
February 20260
March 20267
April 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
Brazil2
Germany1
United Kingdom1
 

Top cities views

Views
Annapolis1
Aracaju1
Ashburn1
Chattanooga1
Contagem1
Frankfurt am Main1
Knoxville1